SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-007725
Filing Date
2024-01-29
Accepted
2024-01-29 16:10:51
Documents
15
Period of Report
2024-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244188d1_8k.htm   iXBRL 8-K 33106
  Complete submission text file 0001104659-24-007725.txt   256992

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA abt-20240129.xsd EX-101.SCH 3369
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abt-20240129_def.xml EX-101.DEF 28284
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE abt-20240129_lab.xml EX-101.LAB 37481
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abt-20240129_pre.xml EX-101.PRE 26508
17 EXTRACTED XBRL INSTANCE DOCUMENT tm244188d1_8k_htm.xml XML 5559
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 24573755
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)